| __timestamp | Bausch Health Companies Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 2917513 |
| Thursday, January 1, 2015 | 2682700000 | 7878291 |
| Friday, January 1, 2016 | 2810000000 | 8366794 |
| Sunday, January 1, 2017 | 2582000000 | 6610381 |
| Monday, January 1, 2018 | 2473000000 | 6556000 |
| Tuesday, January 1, 2019 | 2554000000 | 6930000 |
| Wednesday, January 1, 2020 | 2367000000 | 8758000 |
| Friday, January 1, 2021 | 2624000000 | 10806000 |
| Saturday, January 1, 2022 | 2625000000 | 9844000 |
| Sunday, January 1, 2023 | 2917000000 | 13481000 |
Cracking the code
In the competitive landscape of the pharmaceutical and biotechnology sectors, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Bausch Health Companies Inc. and Soleno Therapeutics, Inc. offer a fascinating study in contrasts. From 2014 to 2023, Bausch Health's SG&A expenses averaged around $2.57 billion annually, with a notable increase of 44% from 2014 to 2023. In contrast, Soleno Therapeutics maintained a much leaner operation, with average annual expenses of approximately $8.2 million, reflecting a 362% increase over the same period. This stark difference highlights Bausch Health's expansive operations compared to Soleno's more focused approach. While Bausch Health's expenses are significantly higher, the scale of their operations justifies this. Soleno's strategy, however, emphasizes cost efficiency, crucial for smaller firms aiming for sustainability. Understanding these dynamics offers valuable insights into strategic financial management in the industry.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Sanofi and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Bausch Health Companies Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.